Jiya Acquisition Corp.
Failed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $100M
- Underwriters
- Focus
- Biopharmaceuticals
- SEC Filings
- 1824119
- Public Embarc Page
- https://embarc.com/capital/spac/1824119/JYAC/jiya-acquisition
- IPO Ticker
- JYAC
SPAC Leadership
Information on the SPAC leadership.
- ChairmanSrinivas Akkaraju, M.D., Ph.D.(Founder/MP, Samsara Biocapital)
- Chief Executive OfficerRekha Hemrajani
- Director, Secretary and Chief Financial OfficerRichard Van Doren
- Chief Investment OfficerCory S. Freedland, Ph.D.
- DirectorPerry Karsen(Chair, Jounce Therapeutics, Fmr COO, Celgene)
- DirectorPamela Klein
- DirectorDaniel Spiegelman
- DirectorSteve Kelsey
- Vice President, Corporate DevelopmentMayank Gandhi, M.D.
- Chief Investment OfficerCory Freedland, Ph.D.